Cleared Traditional

K241328 - aprevo® Anterior and Lateral Lumbar Interbody Fusion device (ALIF/LLIF) (FDA 510(k) Clearance)

Also includes:
aprevo® Transforaminal Lumbar Interbody Fusion device (TLIF) aprevo® Anterior Lumbar Interbody Fusion device with Interfixation (ALIF-X)
Aug 2024
Decision
94d
Days
Class 2
Risk

K241328 is an FDA 510(k) clearance for the aprevo® Anterior and Lateral Lumbar Interbody Fusion device (ALIF/LLIF). This device is classified as a Intervertebral Fusion Device With Bone Graft, Lumbar (Class II - Special Controls, product code MAX).

Submitted by Carlsmed, Inc. (Carlsbad, US). The FDA issued a Cleared decision on August 12, 2024, 94 days after receiving the submission on May 10, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..

Submission Details

510(k) Number K241328 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2024
Decision Date August 12, 2024
Days to Decision 94 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MAX - Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.

Similar Devices - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 82
SWINGO-3D Lumbar Cage System
K254017 · Implanet · Feb 2026
LUX Expandable Lumbar Interbody System
K253583 · Xenix Medical · Feb 2026
Luna® Ti Interbody Fusion System
K250773 · Spinal Elements, Inc. · Feb 2026
Life Spine ProLift & ProLift Lateral and ProLift Lateral Fixated Expandable Spacer System
K253748 · Life Spine, Inc. · Jan 2026
Endoskeleton™ Interbody Systems
K251444 · Medtronic Sofamor Danek USA, Inc. · Sep 2025
MectaLIF 3D Metal
K251016 · Medacta International S.A. · Jul 2025